Meanwhile, in T-cell lymphoma, CD3+/CD21+ (63%), CD4-/CD8-(50%), CD5- (50%), and CD45- (50%) were the most common. This evidence concerns the gene PTPRC and T-cell non-Hodgkin lymphoma.